Using this system, ARF-TK was a more specific inducer of cell death in cancer cells compared to E2F1-KT [158]: ARF-TK showed lower cytotoxicity than E2F1-TK in normal human fibroblasts, but comparable cytotoxicity to E2F1-TK in cancer cells. Here, CDKN2A is linked to cancer.